Stem Cell Therapy Market, by Source (Embryonic Cells, Adult Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells) by Therapy Type (Allogeneic Stem Cell Therapy, and Autologous Stem cell Therapy),by Application (Gastro-Intestine Diseases,

Stem Cell Therapy Market, by Source (Embryonic Cells, Adult Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells) by Therapy Type (Allogeneic Stem Cell Therapy, and Autologous Stem cell Therapy),by Application (Gastro-Intestine Diseases, Central Nervous Diseases, Cardiovascular Diseases, Wounds and Injuries, Eye Diseases, Immune Therapy Diseases, Musculoskeletal Disorders, and Others), by End User (Hospitals and Clinics, and Ambulatory Surgical Centers), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent cells are stem replicating cells which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Market Dynamics

Expansion of facilities related to stem cell therapies is expected to propel growth of the stem cell therapy market. For instance, in January 2018, the University of Florida, U.S. launched the Center for Regenerative Medicine that is focused on development of stem cell therapies for the treatment of damaged tissue and organ. The Centre for Regenerative Medicines is divided into two segments such as focus groups and shared services. Focus groups such as research and development activities for stem cell therapies; and the shared services segment provides technical resources related to stem cell therapies.

Furthermore, rising collaboration activities by key players are expected to drive growth of the global stem cell therapy market. For instance, in May 2018, Procella Therapeutics and Smartwise Medtech Company collaborated with AstraZeneca Pharmaceuticals. Under this collaboration, AstraZeneca was able to utilize Procella Therapeutics’ stem cell technology for development of stem cell therapies in cardiovascular diseases.

Key features of the study:

• This report provides in-depth analysis of the stem cell therapy market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global stem cell therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Osiris Therapeutics, Inc. Novartis AG, GlaxoSmithKline Plc., MEDIPOST Co., Ltd., Anterogen Co., Ltd. Pharmicell Co., Ltd. Holostem Terapie Avanzate S.r.l. JCR Pharmaceuticals Co., Ltd. NuVasive, Inc. RTI Surgical, Inc., and Fibrocell Science, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global stem cell therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for stem cell therapy market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

• Global Stem Cell Therapy Market, By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• Global Stem Cell Therapy market, By Therapy Type:
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• Global Stem Cell Therapy Market, By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• Others
• Global Stem Cell Therapy Market, By End User:
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Global Stem Cell Therapy Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• By Therapy Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• Others
• By End User:
• Hospital and Clinics
• Ambulatory Surgical Center
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• By Therapy Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• Others
• By End User:
• Hospital and Clinics
• Ambulatory Surgical Centers
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• By Therapy Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• Others
• By End User:
• Hospital and Clinics
• Ambulatory Surgical Centers
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• By Therapy Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• By End User:
• Hospital and Clinics
• Ambulatory Surgical Centers
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• By Therapy Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• Others
• By End User:
• Hospital and Clinics
• Ambulatory Surgical Centers
• Africa
• By Country:
• South Africa
• Central Africa
• North Africa
• By Source:
• Embryonic Stem Cells
• Adult Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells
• By Therapy Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• By Application:
• Gastro-Intestine Diseases
• Central Nervous System Diseases
• Cardiovascular Diseases
• Wounds and Injuries
• Eye Diseases
• Immune Therapy Diseases
• Musculoskeletal Disorders
• Others
• By End User:
• Hospital and Clinics
• Ambulatory Surgical Centers
• Company Profiles
• Osiris Therapeutics, Inc. *
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Novartis AG
• GlaxoSmithKline Plc.
• MEDIPOST Co., Ltd.
• Anterogen Co., Ltd.
• Pharmicell Co., Ltd.
• Holostem Terapie Avanzate S.r.l.
• JCR Pharmaceuticals Co., Ltd.
• NuVasive, Inc.
• RTI Surgical, Inc.
• Fibrocell Science, Inc.

“*” marked represents similar segmentation in other categories in the respective section